FDA Adds Boxed Warning Over Injectafer Low Phosphate Risk
FDA added a boxed warning to Injectafer labeling over low blood phosphate risks, advising monitoring for patients receiving repeat courses or facing risk factors closely.
FDA added a boxed warning to Injectafer labeling over low blood phosphate risks, advising monitoring for patients receiving repeat courses or facing risk factors closely.